Atopic Dermatitis Clinical Trials Market In-Depth Analysis By Molecule Type, Study Designs, Phase, Region And Forecasts To 2030
San Francisco, 11 March 2024: The Report Atopic Dermatitis Clinical Trials Market Size, Share & Trends Analysis Report By Molecule Type (Small molecules, Large Molecules), By Study Designs, By Study Phase, By Region, And Segment Forecasts, 2024 - 2030 The global atopic dermatitis clinical trials market is expected to reach USD 4.84 billion by 2030 and expand at a CAGR of 11.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Advancements in biotechnology and medicine, growing prevalence of atopic dermatitis, increasing investments by pharmaceutical companies in the development of novel drugs, rising partnerships and acquisitions among CROs and sponsor companies, technological advancements in clinical research, growing pipeline of atopic dermatitis products, and globalization of clinical trials are few of the factors supporting the lucrative growth of the global market during the forecast period. For pharmaceutical companies, innovation and easy acc